Blocknomi
TLDR Shares of Tyra Biosciences plummeted 22% to $20.96 following underwhelming Phase 2 clinical trial results for its bladder cancer medication dabogratinib The experimental therapy achieved a 64% complete response…
Related articles
-
Satoshi-era Bitcoin wakes after 16 years of dormancy as 600 BTC moves
Cointelegraph Published 06.09.2026 13:01
-
CoinRabbit Wins “Best Crypto Lending Platform 2026” Award from International Business Magazine
Crypto Daily Published 04.09.2026 15:55
-
Bitcoin Defies Seasonal Slump With Third-Best August Ever
Bitcoin Magazine Published 01.09.2026 19:21
-
XRP Price Prediction: Korea and Binance Power the Rally, But Can XRP Keep Going?
Cryptonews Published 26.08.2026 18:44
-
Polish Olympic Committee president detained in Zondacrypto bribery probe
The Block Published 27.08.2026 18:23
-
Bitmine Nears 5% Ethereum Target as Staking Rewards Strengthen Its Position
Blocknomi Published 06.09.2026 21:03
-
Wall Street is now racing to control the $1.9T stablecoin shift to avoid losing its customer base
CryptoSlate Published 02.09.2026 11:15
-
Ripple Price Analysis: XRP Hits Critical Decision Point as Key Support Comes Under Pressure
CryptoPotato Published 31.08.2026 14:23